Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-036395

OncoMed Pharmaceuticals Inc · OMED

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 28, 2015
Accepted (ET)
Sep 30, 2015 · 7:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001302573

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Sep 28, 2015P10,000$14.7353A32,210D
Common StockSep 29, 2015P3,140$14.15A35,350D
Common StockF2holding———1,669,279ISee Footnote
Common StockF3holding———583,428ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses